Variant report
Variant | nsv966766 |
---|---|
Chromosome Location | chr7:26961781-26964055 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140293844 | chr7:26961844-26961845 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201714762 | chr7:26961911-26961912 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566909839 | chr7:26961947-26961948 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535830051 | chr7:26961956-26961957 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188383248 | chr7:26961979-26961980 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575602316 | chr7:26961982-26961983 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377277250 | chr7:26962046-26962047 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs371124831 | chr7:26962081-26962082 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551629562 | chr7:26962114-26962115 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539915684 | chr7:26962117-26962118 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559794278 | chr7:26962123-26962124 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs181665260 | chr7:26962196-26962197 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542206104 | chr7:26962197-26962198 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571703801 | chr7:26962206-26962207 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs143955339 | chr7:26962225-26962226 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185847390 | chr7:26962237-26962238 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144890823 | chr7:26962276-26962277 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570919554 | chr7:26962290-26962291 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs17436236 | chr7:26962349-26962350 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs149043114 | chr7:26962382-26962383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373776674 | chr7:26962406-26962407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535894722 | chr7:26962434-26962435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555759206 | chr7:26962476-26962477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565865004 | chr7:26962518-26962519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs192047037 | chr7:26962553-26962554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537722729 | chr7:26962583-26962584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs774266 | chr7:26962587-26962588 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs183983941 | chr7:26962634-26962635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533988344 | chr7:26962637-26962638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs60717891 | chr7:26962649-26962650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370267274 | chr7:26962669-26962670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187031149 | chr7:26962717-26962718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573360310 | chr7:26962718-26962719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542218323 | chr7:26962719-26962720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs562114574 | chr7:26962743-26962744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs17436249 | chr7:26962805-26962806 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs575906375 | chr7:26962812-26962813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552486213 | chr7:26962828-26962829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564781903 | chr7:26962829-26962830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191128749 | chr7:26962856-26962857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143385212 | chr7:26962919-26962920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs17436256 | chr7:26962957-26962958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529360761 | chr7:26962995-26962996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs549422310 | chr7:26963044-26963045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs79893248 | chr7:26963052-26963053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376857324 | chr7:26963144-26963145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551433324 | chr7:26963192-26963193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs536901366 | chr7:26963203-26963204 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182109475 | chr7:26963239-26963240 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs13229517 | chr7:26963243-26963244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Cancer | 21183584 | CNVD |
abnormal development | 18461090 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Lung cancer | 17086460 | CNVD |
Breast cancer | 18852474 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Cancer | 17440070 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:26957000-26962200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr7:26957400-26962400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr7:26960400-26969600 | Weak transcription | NHEK | skin |
4 | chr7:26960800-26963400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr7:26961000-26962200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr7:26961400-26961800 | Enhancers | HMEC | breast |
7 | chr7:26962200-26963200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr7:26963200-26963400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr7:26963400-26963600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |